LOGO.png
IMAC Holdings Annual Meeting of Shareholders Reminder
June 28, 2023 16:30 ET | IMAC Holdings, Inc.
Shareholders are reminded to vote their shares prior to the proxy voting deadline of 7:00pm on July 4, 2023 FRANKLIN, Tenn., June 28, 2023 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK)...
LOGO.png
Theralink® Signs Definitive Merger Agreement to be Acquired by IMAC Holdings, a Nasdaq Listed Company
May 23, 2023 09:43 ET | IMAC Holdings, Inc.
Theralink’s patented technology is helping to solve a significant problem in cancer treatment by providing game changing technology that can predict FDA-approved drugs that may be effective in each...
LOGO.png
IMAC Holdings Reports Year End 2022 Financial Results and Corporate Update
March 31, 2023 20:00 ET | IMAC Holdings, Inc.
Revenue increased 14% annually driven by greater adoption of medical treatments. BRENTWOOD, Tenn., March 31, 2023 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC” or the “Company”), a...
LOGO.png
IMAC Holdings and Brain Scientific Announce a Strategic Merger to Create Synergistic End-To-End Neurological Solution
March 20, 2023 07:30 ET | IMAC Holdings, Inc.
Combined company will provide total solutions, from diagnosis to treatment, for patients with neurological disorders including Parkinson’s, Alzheimer's, and stroke. BRENTWOOD, Tenn. and LAKEWOOD...
LOGO.png
IMAC Holdings, Inc announces the sale of The BackSpace
March 01, 2023 09:30 ET | IMAC Holdings, Inc.
BRENTWOOD, Tenn., March 01, 2023 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC” or the “Company”), announces today it has completed the sale of The BackSpace for an undisclosed price...
LOGO.png
IMAC Holdings Announces Third Quarter Results
November 15, 2022 06:00 ET | IMAC Holdings, Inc.
Company Reports Sixth Consecutive Quarter of Comparable Revenue Growth BRENTWOOD, Tenn., Nov. 15, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC” “BACK” or the “Company”), today...
LOGO.png
IMAC Holdings, Inc. Launches E-Commerce Website for Vitamin and Supplement Line
November 03, 2022 08:30 ET | IMAC Holdings, Inc.
BRENTWOOD, Tenn., Nov. 03, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC” or the “Company”), announces today it has launched an e-commerce platform to retail its vitamin and...
LOGO.png
IMAC Holdings, Inc. Hosts Hall of Fame Athlete Panel at the Evoke Conference to Launch Whole Food Supplement Partnership
October 21, 2022 10:30 ET | IMAC Holdings, Inc.
BRENTWOOD, Tenn., Oct. 21, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC” or the “Company”), announces today it is partnering with Evoke Chiropractic Coaching to educate and...
LOGO.png
IMAC Holdings, Inc. Announces Completion of Third Cohort of its Phase 1 Clinical Study of Umbilical Cord-Derived Mesenchymal Stem Cells for the Treatment of Bradykinesia Due to Parkinson’s Disease
September 09, 2022 09:22 ET | IMAC Holdings, Inc.
BRENTWOOD, Tenn., Sept. 09, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC” or “the Company”), today announces it has completed the third cohort of its Phase 1 clinical trial for...
LOGO.png
Biote Announces Strategic Partnership with IMAC Holdings, Inc.
September 07, 2022 08:30 ET | IMAC Holdings, Inc.
Biote Method to be available in IMAC outpatient medical clinics IRVING, TX, Sept. 07, 2022 (GLOBE NEWSWIRE) -- biote Corp. (Nasdaq: BTMD)(“Biote” or the “Company”), a high growth, differentiated...